Aurenar

Aurenar is a healthcare company in St. Louis, United States. It has raised $5.7M across 1 round, most recently a $5.7M Seed in July 2026.

Headquarters
St. Louis
Employees
1–10
Business Model
B2B
Total Funding
$5.7M
Last Round
$5.7M SeedJul 2026
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

Aurenar is a company developing a non-invasive, single-use neuromodulation platform to reduce life-threatening complications in ICU patients. The company's transauricular vagus nerve stimulation (taVNS) device targets the body's inflammatory response to improve outcomes, lower total cost of care, and transform critical care management. Beginning with the impacts of stroke, Aurenar's platform is positioned to expand to address multiple high-acuity indications. Aurenar is headquartered in St. Louis, Missouri.

Summary

It lists 1–10 employees. It has raised $5.7M in total across 1 round, most recently a $5.7M Seed round in Jul 2026. Investors include Go Red for Women Venture Fund.

Funding History

Data from Indexed.vcUpdated
SeedJul 2026
$5.7M

Investors

Similar Companies

Neko Health

Neko Health delivers preventive health scans that combine skin, heart, blood, and body measuremen...

Stockholm, Sweden201–500Artificial Intelligence, Digital Health
Series CTotal funding$1.1BJul 2026
MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Aurenar on Indexed.vc
<a href="https://indexed.vc/companies/aurenar"><img src="https://indexed.vc/api/badge/company/aurenar" alt="Aurenar on Indexed.vc" width="260" height="76" /></a>